Cellosaurus cell line FHS050i-sh2633D (CVCL

Cellosaurus FHS050i-sh2633D (CVCL_YY81)

Cross-references
Cell line name	FHS050i-sh2633D
Synonyms	iPSC - 2633D
Accession	CVCL_YY81
Resource Identification Initiative	To cite this cell line use: FHS050i-sh2633D (RRID:CVCL_YY81)
Comments	Part of: Framingham Heart Study (FHS) collection. Part of: Next Generation Genetic Association studies (Next Gen) program cell lines. Population: Caucasian. Omics: Transcriptomics; RNAseq. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Sequence variations	Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T; dbSNP=rs12740374; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual	CVCL_YY80 ! FHS049i-sh2633B
Sex of cell	Female
Age at sampling	61-70Y
Category	Induced pluripotent stem cell
Publications	PubMed=28388431; DOI=10.1016/j.stem.2017.01.010 Curtis R. Warren, John F. O'Sullivan, Max Friesen, Caroline E. Becker, Xiao-Ling Zhang, Po-Ching Liu, Yoshiyuki Wakabayashi, Jordan E. Morningstar, Xu Shi, Jihoon Choi, Fang Xia ...Show all 28 authors... , Derek Tilghman Peters, Mary Heather Celine Florido, Alexander M. Tsankov, Eilene A. Duberow, Lauren Comisar, Jennifer Shay, Xin Jiang, Alexander Meissner, Kiran Musunuru, Sekar Kathiresan, Laurence Daheron, Jun Zhu, Robert Edgardo Gerszten, Rahul C. Deo, Ramachandran S. Vasan, Christopher J. O'Donnell, Chad A. Cowan; Show fewer authors Induced pluripotent stem cell differentiation enables functional validation of GWAS variants in metabolic disease. Cell Stem Cell 20:547-557.e7(2017)
Cell line collections (Providers)	WiCell; fhs050i-sh2633d
Biological sample resources	BioSample; SAMN06093564
Encyclopedic resources	Wikidata; Q98126197
Gene expression databases	GEO; GSM2411828
Entry history
Entry creation	02-Jul-2020
Last entry update	10-Apr-2025
Version number	9